James M. Youakim - Concepedia

Author

James M. Youakim

Acadia Pharmaceuticals (United States)ORCID

Also Known As

J Youakim, J. Youakim, J.M. Youakim, James M Youakim, James M. Youakim, James Youakim, JamesM. Youakim

Publications

Citations

H-Index

Concepts

All Affiliations

Acadia Pharmaceuticals (United States)Vanderbilt University Medical Center Texas Children's Hospital University of Alabama at Birmingham University of Colorado Denver

About

James M. Youakim is an author at Acadia Pharmaceuticals (United States) specializing in medicine, psychiatry, and sleep.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	383
2	Health Sciences	1	1	187
3	Social Sciences	1	1	15
4	Neurology	1	1	187
5	Otolaryngology	1	1	24

James M. Youakim

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study Clive Ballard, Carol Banister, Zunera Khan, The Lancet Neurology Disease PsychosisAlzheimer's DiseasePsychiatryDementiaPimavanserin Versus Placebo	2018	187
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study Jeffrey L. Neul, Alan K. Percy, Tim A. Benke, Nature Medicine	2023	173
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder Michael E. Thase, James M. Youakim, Aleksandar Skuban, The Journal of Clinical Psychiatry	2015	171
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants Michael E. Thase, James M. Youakim, Aleksandar Skuban, The Journal of Clinical Psychiatry	2015	160
Trial of Pimavanserin in Dementia-Related Psychosis Pierre N. Tariot, Jeffrey L. Cummings, Maria Soto‐Martin, New England Journal of Medicine	2021	127
Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder Joseph R. Calabrese, Terence A. Ketter, James M. Youakim, The Journal of Clinical Psychiatry	2010	115
Posttraumatic Stress Disorder and Obstructive Sleep Apnea Syndrome James M. Youakim, Karl Doghramji, Sharon L. Schutte Psychosomatics SleepSleep DisorderSleep-related Breathing DisorderObstructive Sleep ApneaPsychiatry	1998	72
Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome Jeffrey L. Neul, Alan K. Percy, Tim A. Benke, Contemporary Clinical Trials	2022	66
Revisiting Criteria for Psychosis in Alzheimer’s Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research Corinne E. Fischer, Zahinoor Ismail, James M. Youakim, Journal of Alzheimer s Disease	2019	63
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness Associated With Jet Lag Disorder Russell Rosenberg, Richard Bogan, Jane Tiller, Mayo Clinic Proceedings Sleep DisordersSleepSleep MedicineSleep DisorderPsychiatry	2010	54

Page 1